24 April 2014 - Advanced wound care company Alliqua (ALQA) said on Wednesday that it will showcase its Biovance human amniotic membrane allograft product at the Spring 2014 Symposium on Advanced Wound Care to be held at the Gaylord Palms Hotel and Convention Centre in Orlando, Florida between 23-27 April.

Currently, Biovance is being manufactured through a supply agreement with Celgene Cellular Therapeutics (CCT) to assist wound care specialists, physicians and nurses, as well as vascular, plastic and general surgeons, in the treatment of a wide variety of complex, acute, chronic, recalcitrant, full and partial thickness wound types.

Following the Symposium, Alliqua will begin sales of Biovance with immediate effect through its team of direct sales representatives.

Additionally, Dr Terry Treadwell and Donna Walker, LPN (Institute for Advanced Wound Care, Montgomery, AL) have authored a poster that will be on display during SAWC (CR_049) titled 'Treatment of Second Degree Burns with Dehydrated, Decellularized Amniotic Membrane (Biovance) versus a Nanocrystalline Silver Dressing'.